InnoCan PharmaINNPF -10.53%56 Quick Ratio is 4.40 as of Mar. 2026, which is 80% above its 10-year median of 2.45. GuruFocus rates INNPF with a GF Score™ of 56/100 and a GF Value™ of $10.03 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,986 Consumer Packaged Goods companies, InnoCan Pharma ranks better than 90.58% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. InnoCan Pharma's quick ratio for the quarter that ended in Mar. 2026 was 4.40.
InnoCan Pharma has a quick ratio of 4.40. It generally indicates good short-term financial strength.
The historical rank and industry rank for InnoCan Pharma's Quick Ratio or its related term are showing as below:
INNPF'
s Quick Ratio Range Over the Past 10 Years
Min: 0.48 Med: 2.45 Max: 7.86
Current: 4.4
During the past 8 years, InnoCan Pharma's highest Quick Ratio was 7.86. The lowest was 0.48. And the median was 2.45.
INNPF's Quick Ratio is ranked better than 90.58% of 1986
companies
in the Consumer Packaged Goods industry
Industry Median: 1.12
vs INNPF: 4.40
InnoCan Pharma (OTCPK:INNPF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
InnoCan Pharma Quick Ratio Related Terms
InnoCan Pharma Quick Ratio Historical Data
* Premium members only.
The historical data trend for InnoCan Pharma's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, InnoCan Pharma's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnoCan Pharma Quick Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, InnoCan Pharma's Quick Ratio distribution charts can be found below:
* The bar in red indicates where InnoCan Pharma's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
InnoCan Pharma's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnoCan Pharma (INNPF) has a Quick Ratio of 4.40 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on InnoCan Pharma and its competitors. This is 80% above median its historical median of 2.45. Over the past decade, InnoCan Pharma's Quick Ratio has ranged from 0.48 to 7.86. According to the industry distribution chart, InnoCan Pharma ranks #187 out of 1986 companies in the Consumer Packaged Goods industry, placing it in the top 9.4%.
Is InnoCan Pharma's Quick Ratio too high?
InnoCan Pharma's current Quick Ratio of 4.40 is 80% above median its 10-year median of 2.45. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 7.86. The Consumer Packaged Goods industry median Quick Ratio is 1.12. InnoCan Pharma's value of 4.40 is 292.9% above this industry median. Based on the distribution chart, InnoCan Pharma ranks #187 out of 1986 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, InnoCan Pharma has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does InnoCan Pharma's Quick Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, InnoCan Pharma ranks #187 out of 1986 companies for Quick Ratio. This places InnoCan Pharma in the top 9% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.12. InnoCan Pharma's value of 4.40 is 292.9% above this benchmark. Historically, InnoCan Pharma's own Quick Ratio has ranged from 0.48 to 7.86 over the past decade. While the company's 10-year median is 2.45 vs. the industry median of 1.12, InnoCan Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Consumer Packaged Goods company?
The median Quick Ratio among Consumer Packaged Goods companies is 1.12, based on 1,986 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InnoCan Pharma's current Quick Ratio of 4.40 is 292.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on InnoCan Pharma and its competitors. For the Consumer Packaged Goods industry, the median Quick Ratio is 1.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnoCan Pharma's current Quick Ratio is 4.40, which is 80% above median its own 10-year median of 2.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnoCan Pharma stock overvalued right now?
Based on GuruFocus' analysis, InnoCan Pharma (INNPF) is currently considered Possible Value Trap. The stock's GF Value™ is $10.03, compared to a current price of $1.70 — trading 83.1% below its estimated fair value. The current Quick Ratio is 4.40, which is 80% above median its 10-year median of 2.45 and 292.9% above the Consumer Packaged Goods industry median of 1.12. InnoCan Pharma's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For InnoCan Pharma (INNPF), the current Quick Ratio is 4.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnoCan Pharma (INNPF) Overvalued in 2026?
Based on GuruFocus' analysis, InnoCan Pharma stock appears to be undervalued.
The current stock price of $1.70 is trading 83.1% below its estimated GF Value™ of $10.03.
GuruFocus considers InnoCan Pharma to be Possible Value Trap.
Key valuation signals for INNPF:
Quick Ratio: 4.40 (80% above median its 10-year median of 2.45)
GF Value™: $10.03 vs. price of $1.70 (83.1% below fair value)
Industry Position: 292.9% above the Consumer Packaged Goods median (#187 of 1986)
No single metric tells the full story. See the INNPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnoCan Pharma Corp develops consumer wellness and pharmaceutical products. It has developed a preclinical-stage Cannabidiol-loaded Liposome injection Platform (CBD-LPT) for non-opioid pain management, and is involved in developing and marketing various self-care and CBD beauty products. Additionally, the Group offers cosmetic products such as anti-aging beauty sleeping masks, anti-puffiness eye serum, anti-aging facial serum, hair cream, etc., which are sold mainly through online marketplaces. Its operating segments are: Online sales and Other operations. The majority of its revenue is generated from the Online sales segment, which engages in the development, manufacture, and marketing of cosmetic products. Geographically, the Group generates maximum revenue from the United States.
56GF Score
Get the complete analysis for INNPF
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INNPF has been successfully added to your 
